AI assistant
RAPT Therapeutics, Inc. — Director's Dealing 2019
Nov 15, 2019
32942_dirs_2019-11-15_c2efee8d-d6d0-4aa0-9e69-03685b970146.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2019-11-04
Reporting Person: Topspin Fund L.P. (10% Owner)
Reporting Person: Topspin Biotech Fund II, L.P. (10% Owner)
Reporting Person: LG Management, LLC (10% Owner)
Reporting Person: GUTHART LEO (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-04 | Common Stock | P | 415000 | $12.00 | Acquired | 2575371 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-11-04 | Series B Preferred Stock | $ | C | 1641666 | Disposed | Common Stock (1641666) | Indirect | |
| 2019-11-04 | Series C Preferred Stock | $ | C | 363504 | Disposed | Common Stock (363504) | Direct | |
| 2019-11-04 | Series C-2 Preferred Stock | $ | C | 155201 | Disposed | Common Stock (155201) | Direct |
Footnotes
F1: Consists of (1) 1,641,666 shares held of record by Topspin Biotech Fund II, LP; and (ii) 933,705 shares held of record by Topspin Fund, LP. Each of Topspin Biotech Fund II, LP and Topspin Fund, LP disclaims beneficial ownership of the shares held of record by the other.
F2: Each share of Series B, C and C-2 Preferred Stock shown in Column 5 converted into one share of Common Stock automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. Giving effect to such conversion, the ownership by the reporting persons of the shares of the Issuer's common stock is as set forth in Note 1 above.
F3: 1,641,666 of such shares are held directly by Topspin Biotech Fund II, L.P. LG Management, LLC, the general partner of Topspin Biotech Fund II, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.
F4: 933,705 of such shares are held directly by Topspin Fund L.P. LG Management, LLC, the general partner of Topspin Fund L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.